Minrad and Piramal to Merge
Piramal Healthcare Limited will acquire Minrad International for $.12 per share plus the assumption of debt. The total transaction, valued at approximately $40 million, is […]
Articles by Doug Cress
NovaDel: Longs May Finally Get a Good Night’s Sleep
The FDA has approved NovaDel’s Zolpimist, an oral spray for the short-term treatment of insomnia. Zolpimist contains zolpidem tartrate, the same active ingredient found in […]
[Incubator Profile] UAMS BioVentures
OneMedPlace would like to welcome UAMS BioVentures as a founding member of our Portfolio Development Group. BioVentures, will discuss its innovative business practices at the […]
[Company Profile] OptiNose
OptiNose’s breath-actuated devices deliver intranasal drugs to targeted regions of the nasal cavity, including the sinuses and the olfactory region, without lung deposition, a major […]
AngioDynamics’ NanoKnife: “Unique and Remarkable” Absence of Post-Operative Pain
AngioDynamics announced the use of its Irreversible Electroporation (IRE) technology on a lymph node metastasis and the first lung lesion case. The procedures were judged […]
CompuMed Secures $4 Million for Strategic Initiatives
CompuMed has secured a $4 million line of credit, allowing the telemedicine company to pursue strategic initiatives even in this challenging financing environment. The funds […]
Citing a Lack of Funds, PLC Systems Defers RenalGuard Trial
It’s been over 18 months since PLC Systems enrolled the first patients in its RenalGuard clinical trial. It now appears the company’s efforts may have […]
Synthes Prevails Against Medtronic
Synthes, a maker of spine and bone implants, has prevailed in a court battle with device-giant Medtronic. Synthes alleged that Medtronic had willfully infringed on […]
Synergetics USA: Shift in Corporate Strategy Yields Strong First Quarter Results
Synergetics USA reported first quarter revenues of $12.2 million, an increase of 17% over the year ago period. More compelling was the increase in net […]
Patient Enrollment for Monovisc U.S. Clinical Trial Complete
Anika Therapeutics, a developer of products for tissue protection, healing and repair, has completed patient enrollment for its Monovisc U.S. clinical trial. The randomized, double-blind […]